tirzepatide ilaç equally effective for early-onset or later-onset type 2 diabetes China Clears Eli Lilly's Weight

In November 2025, Brazilian courts denied a request from Novo Nordisk to extend the medical patent for 5 years

GLP-1 medication and weight loss: Barriers and motivators among 1659 participants managed in a virtual setting

This might be due to reduced or interrupted insulin doses, gastrointestinal AEs (e.g., vomiting, dehydration), and decreased appetite leading to reduced food intake 27

This powerful medication, recognized for its effectiveness in weight management and diabetes control, requires careful handling to ensure its potency and safety

Presented for research literature review only Bioletto F et al

Also, possible development of thyroid tumors, including thyroid cancer